Abstract
"HSR21-073: Febrile Neutropenia Outcomes Among Patients With Breast Cancer and Non-Hodgkin’s Lymphoma Receiving Pegfilgrastim Prophylaxis: A Real-World Analysis of Commercial and Medicare Claims From 2017-2018" published on 17 Mar 2021 by National Comprehensive Cancer Network.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have